TY  - JOUR

T1  - Practical management of the JAK1 inhibitor abrocitinib for atopic dermatitis in clinical practice: special safety considerations

JO  - Dermatology and Therapy

UR  - https://eprints.whiterose.ac.uk/id/eprint/215601

PY  - 2024/07/02

AU  - Gooderham MJ

AU  - de Bruin-Weller M

AU  - Weidinger S

AU  - Cork MJ

AU  - Eichenfield LF

AU  - Simpson EL

AU  - Tsianakas A

AU  - Kerkmann U

AU  - Feeney C

AU  - Romero W

ED  - 

DO  - DOI: 10.1007/s13555-024-01200-5

PB  - Springer Science and Business Media LLC

VL  - 14

IS  - 8

SP  - 2285

EP  - 2296,

Y2  - 2025/11/05

ER  -